Overview

An Open Study to Assess the Robustness of the CRC749 Inhaler

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To confirm the robustness of the CRC749 inhaler.
Phase:
Phase 1
Details
Lead Sponsor:
Mylan Inc.
Collaborator:
Mylan Pharmaceuticals